sever
serolog
interrelationship
variou
member
coronaviru
group
reveal
neutral
complement
fixat
geldiffus
test
use
human
hyperimmun
anim
sera
sever
member
group
human
anim
pathogen
shown
crossreact
one
type
test
one
member
avian
infecti
bronchiti
viru
shown
unrel
mous
hepat
viru
mhv
found
antigeni
relat
number
human
type
coronaviru
difficulti
encount
investig
pair
human
sera
demonstr
specif
antibodi
rise
place
doubt
valu
serolog
studi
signific
interrelationship
discuss
light
investig
bradburn
antigen
relationship
amongst
coronavirus
organ
cultur
human
embryo
nasal
tracheal
epithelium
isol
compris
least
three
probabl
distinct
serolog
type
judg
neutral
test
use
convalesc
human
sera
ba
bur
triil
mcito
et
al
work
describ
detect
sever
serolog
relationship
virus
isol
man
mous
hepat
avian
infecti
bronchiti
major
result
obtain
similar
studi
report
mcinto
et
al
furthermor
differ
reagent
use
sever
extra
crossreact
detect
tissu
cultur
propag
laboratori
roller
tube
neutral
test
perform
monolay
cultur
human
embryo
diploid
lung
cell
hdc
either
strain
deriv
unit
cell
strain
plaqu
neutral
test
made
use
monolay
l
cell
mm
plastic
pctri
dish
sterilin
l
cell
line
continu
epitheloid
cell
line
deriv
human
embryo
lung
davi
shown
sensit
sever
respiratori
virus
includ
strain
coronavirus
brad
vln
cultur
maintain
inocul
new
group
virus
isol
case
upper
respiratori
diseas
man
virus
common
morpholog
virus
avian
infecti
bronchiti
beri
et
al
mous
hepat
tyrrel
almeida
agent
ether
acidlabil
probabl
contain
rna
compos
pleomorph
bodi
diamet
neg
stain
seen
surround
fring
clubshap
project
deep
resembl
fring
crown
result
name
coronavirus
propos
group
natur
mani
isol
made
avian
infecti
bronchiti
aib
serolog
fall
sever
serolog
type
basi
neutral
test
estola
least
three
serolog
type
mous
hepat
viru
mttv
gl
dll
isol
coronavirus
man
made
human
embryo
diploid
lung
cell
strain
ttdc
isol
crossreact
complet
neutral
test
antisera
prototyp
strain
isol
hamr
prockow
virus
group
pathogen
man
isol
isol
dr
hamrc
propag
cell
cultur
viru
strain
isol
mcintosh
human
tracheal
organ
cultur
mcitosi
et
al
adapt
infect
suckl
mice
intraeerebr
rout
mcinoslz
b
c
wr
canocx
viru
propag
intracerebr
inocul
dayold
mice
porton
albino
strain
mous
hepat
viru
strain
mhv
obtain
late
dr
gledhil
cultiv
weanl
mice
brain
suckl
mice
primari
mous
macrophagc
cultur
obtain
periton
lavagc
stimul
anim
starch
broth
b
und
lp
virus
tyien
oil
tyrrel
byno
hook
use
pool
prepar
infect
l
cell
avian
infecti
bronchiti
viru
beaudctt
strain
obtain
mr
r
henri
use
infecti
suckl
mous
brain
allanto
fluid
obtain
inocul
embryon
egg
volunt
inocul
coronaviru
isol
made
man
inocula
use
either
infecti
organ
cultur
fluid
nasal
wash
taken
broth
salin
pair
serum
sampl
taken
person
one
inocul
one
three
week
later
hyperimmun
anim
sera
rais
either
rabbit
intramuscular
inject
incomplet
freund
adjuv
follow
intraven
challeng
antigen
mice
product
immun
ascit
fluid
method
sommervil
soeru
wherev
possibl
mice
immunis
suspens
infect
mous
brain
avoid
product
antitissu
antibodi
possibl
anim
inocul
tissu
cultur
pool
viru
prepar
monolaycr
wash
free
serum
infect
cytopath
effect
appear
cultur
frozen
thaw
concentr
dialysi
polyethylen
glycol
peg
clarifi
eentrffug
immun
mous
sera
r
lihv
prepar
inocul
weanl
mice
mldso
viru
survivor
exsanguin
four
week
later
porton
albino
mice
use
antibodi
mhvx
mhva
prior
immun
highli
suscept
pathogen
sera
inactiv
minut
neutral
test
complement
fixat
test
hyperimmun
asciti
fluid
human
rabbit
sera
use
complement
fixat
test
inactiv
minut
remov
anticomplementari
activ
test
prepar
viru
known
titr
dilut
special
diluent
contain
nutrient
broth
hank
bss
final
bovin
plasma
albumin
dilut
suspens
centrifug
g
minut
store
tissu
cultur
neutral
test
approxim
tcdsoml
hdc
pfuml
l
cell
appropri
viru
mix
equal
volum
dilut
inactiv
sera
maintain
room
temperatur
hour
ml
aiiquot
inocul
roller
tube
cultur
hdc
cell
tube
examin
cytopath
effect
day
plaqu
reduct
test
perform
monolay
l
ceil
mm
petri
dish
inocul
ml
virusserum
mixtur
absorb
hour
overlaid
medium
describ
bradbui
tyirel
plaqu
count
day
incub
neutral
test
mttv
viru
perform
similar
manner
viru
inocul
cultur
primari
mous
periton
macrophag
infecti
bronchiti
viru
ibv
beaudett
test
system
use
primari
chick
embryo
kidney
prepar
method
estola
neutral
test
viru
carri
suckl
mice
intracerebr
inocul
virusserum
mixtur
virusserum
mixtur
plate
tube
use
tissu
cultur
neutral
test
least
mice
mous
neutral
test
neutral
endpoint
plaqu
reduct
test
determin
dilut
serum
would
produc
reduct
control
plaqu
count
tube
neutral
test
end
point
determin
fhe
method
rend
muenc
test
kay
dowdl
report
hightitr
prepar
mous
brain
agglutin
human
rat
mous
chicken
red
cell
variou
temperatur
confirm
use
antigen
made
homogenis
infect
mous
brain
concentr
phosphat
buffer
salin
ph
clarifi
eentrifug
g
minut
although
rat
mous
cell
sensit
haemagglutin
test
often
settl
satisfactorili
therefor
chicken
erythrocyt
use
haemagglutinationinhibit
hi
test
aggiutin
dose
viru
use
test
perform
microtitr
plate
use
ml
dropvolum
antisera
inactiv
minut
react
viru
hour
room
temperatur
chicken
erythrocyt
ad
allow
settl
minnt
test
read
immedi
attempt
made
detect
haemagglutin
eoronaviru
antigen
includ
extract
mous
brain
infect
mhv
mhv
aib
virus
unsuccess
complement
fixat
test
carri
mierotitr
method
takatsi
seve
use
ml
volum
specif
fixat
reveal
low
dose
complement
use
test
haemolyti
unit
complement
employ
use
overnight
fixat
complement
dose
determin
prepar
closerang
dilut
solut
complement
triplic
estim
parallel
rest
test
possibl
aib
suspens
infect
suckl
mous
brain
use
cf
antigen
clarifi
eentrifug
g
antigen
coronavirus
could
cultiv
tissu
cultur
partial
pmifi
gel
filtrat
tissu
cultur
pool
viru
prepar
serumfre
medium
homogenis
concentr
dialysi
peg
clarifi
eentrifug
filter
column
gel
materi
exclud
gel
concentr
dialysi
frozen
use
geldiffus
test
done
micromethod
crowl
use
agar
oxoid
phosphat
buffer
salin
ph
contain
phenol
sodium
azid
test
set
microscop
slide
use
perspex
templat
reagent
allow
diffus
hour
room
temperatur
templat
remov
slide
wash
overnight
pb
photograph
darkground
illumin
result
pair
sara
taken
volunt
infect
lp
viru
show
signific
rise
neutral
antibodi
viras
rollertub
plaquereduct
test
antibodi
respons
tabl
emphas
limit
number
sera
avail
volunt
infect
screen
antibodi
rise
infect
strain
difficulti
manipul
virus
five
pair
sera
show
greater
rise
antibodi
titr
lp
virus
respect
also
test
mhv
aib
rise
neutral
antibodi
direct
detect
none
sera
develop
antibodi
aib
even
serum
dilut
immun
respons
detect
lp
virus
volunt
sera
necessarili
greatest
homolog
viru
shown
af
bradulcn
fig
one
sure
whether
antibodi
rise
detect
human
volunt
result
viru
infect
given
experiment
may
influenc
previou
infect
relat
virus
clarifi
situat
hyperimmun
ascit
fluid
mice
expos
one
coronaviru
studi
possibl
plaqu
reduct
test
employ
prove
sensit
assay
neutral
cytopathio
effect
roller
tube
cultur
result
shown
tabl
sera
direct
lp
viru
neutral
e
antiserum
e
viru
almost
fail
neutral
lp
tube
neutral
test
mous
aseit
stimul
viru
neutral
viru
lower
dilut
ascit
fluid
mice
hyperimmun
viru
neutral
effect
viru
suckl
mice
neutral
lp
plaqu
repeatedli
homolog
titr
hyperimmun
ascitio
fluid
mhva
aib
beaudett
virus
neutral
lp
virus
scra
volunt
given
b
viru
rise
neutral
antibodi
titr
b
sera
select
show
signific
rise
homolog
vh
sera
select
volunt
cold
cross
reaction
confirm
perform
kinet
neutral
test
determin
neutral
constant
k
hyperimmun
serum
dilut
inactiv
salin
lp
virus
small
nonneutrmiz
fraction
viru
k
valu
indic
antiserum
lp
viru
neutral
lp
e
roughli
rate
wmle
antisera
viru
neutral
lp
less
rapidli
result
tabl
thu
similar
previou
test
effect
complement
plaquereduct
assay
titrat
antisera
e
lp
virus
investig
complement
mark
effect
neutral
envelop
virus
virusserum
mixtur
made
diluent
contain
final
fresh
rabbit
serum
diluent
inhibitori
effect
virus
twohour
reaction
period
compar
dilut
made
medium
contain
heat
rabbit
serum
complement
found
neither
increas
decreas
titr
antisera
obtain
lp
virus
absenc
furthermor
heterolog
reaction
promin
absenc
complement
variou
antihuman
sera
test
two
virus
system
antihost
antisera
shown
neutralis
infecti
bronchiti
viru
berri
almida
sera
test
one
serum
activ
serum
prepar
rabbit
method
alreadi
describ
antigen
use
intramuscular
inject
uninfect
hdc
lung
cell
intraven
inject
extract
normal
human
embryo
lung
neutralis
complement
rabbit
serum
present
lp
unaffect
titr
cytotox
titr
l
cell
agglutinin
titr
human
erythrocyt
pr
plaqu
reduct
titr
sm
endpoint
titr
suckl
mice
test
use
infecti
unit
viru
kay
dow
jje
report
mousebrain
antigen
react
polyval
antiserum
mous
hepat
viru
hi
test
cross
reaction
confirm
studi
mous
antiscra
mous
hepat
virus
mhv
mhv
virus
test
hi
hi
titr
respect
sera
titr
greater
mous
neutral
test
hyperimmun
antisera
coronavirus
fail
give
reaction
dilut
greater
pair
sera
taken
volunt
infect
variou
coronavirns
except
test
hi
sera
greater
rise
hi
earli
stage
investig
found
result
complement
fixat
test
use
coronaviru
antigen
seldom
constant
repeat
nonreproduc
report
other
mcitosh
et
al
titr
antisera
use
found
except
depend
upon
exact
quantiti
complement
use
overnight
fixat
use
standard
quantiti
complement
two
haemolyt
unit
high
af
bradburn
titr
hyperimmun
sera
potent
antigen
gave
complet
fixat
use
lower
dose
complement
titr
sera
increas
consider
therefor
test
quot
repeat
confirm
result
dose
complement
usual
kept
unit
depend
test
quantiti
complement
use
demonstr
use
singl
antigen
mhvainfect
mous
brain
five
differ
antisera
variou
dilut
complement
result
shown
fig
seen
apart
serum
result
normal
infect
mhv
sera
uniform
respons
complement
rang
unit
show
maxima
minima
reaction
variat
complementfix
equival
reproduc
term
maxima
minima
shown
actual
titr
obtain
probabl
difficulti
exact
determin
dose
complement
unit
complement
sera
show
maximum
reactiv
use
crude
tissu
cultur
fluid
antigen
volunt
convalesc
sera
show
detect
level
complement
fixat
therefor
tissu
cultur
fluid
concentr
dialysi
result
fluid
often
anticomplementari
found
anticomplementari
activ
remov
filtrat
sephadex
gel
describ
materi
method
use
antigen
signific
antibodi
rise
lp
found
serum
pair
taken
volunt
cold
induc
lp
virus
neutral
antibodi
rise
infect
either
virus
produc
rise
complementfix
antibodi
serum
pair
taken
volunt
infect
lp
virus
none
rise
cf
titr
pair
show
rise
iiyperimmun
ascit
fluid
produc
eoronavirus
could
grown
human
tissu
cultur
cell
contain
antihuman
activ
iowev
hyperimmun
ascit
fluid
least
higher
titr
antigen
prepar
infect
l
cell
uninfect
tissu
cultur
antigen
ascit
fluid
antisera
prepar
mice
use
infect
mous
brain
inocula
aib
mhv
virus
fix
complement
dilut
greater
normal
mous
brain
uninfect
l
cell
antigen
chequerboard
complement
fixat
test
perform
day
hyperimmun
sera
set
antigen
sever
crossreact
reveal
shown
tabl
chequerboard
titrat
necessari
prozon
occur
hightitr
sera
test
reaction
reproduc
repeat
test
titr
obtain
ident
homolog
mixtur
usual
fix
complement
well
heterolog
reaction
often
use
less
unit
complement
never
observ
antisera
lp
e
b
virus
fix
complement
antigen
antiserum
viru
fix
complement
antigen
af
brdburn
virus
mhv
viru
also
show
reciproc
crossreact
lp
virus
use
hyperimmun
ascit
mhv
antigen
also
fix
complement
ascit
fluid
precipitin
line
detect
human
sera
eoronaviru
antigen
prepar
tissu
cultur
latter
concentr
antigen
react
convalesc
sera
volunt
given
viru
precipitin
line
lp
antigen
regularli
seen
line
fulli
develop
hour
reaction
ident
line
produc
two
antigen
howev
sera
taken
volunt
infect
lp
viru
produc
reciprocm
titr
obtain
complement
fixat
test
use
hyperimmun
mous
aseit
fluid
variou
coronaviru
antisera
test
unit
complement
use
unit
antigen
ascit
produc
inocul
mice
viru
grown
cell
therefor
antihuman
reaction
may
involv
complement
fixat
antigen
produc
cell
nr
result
reliabl
antitissu
reaction
line
precipit
lp
antigen
two
ident
line
produc
antigen
third
line
produc
lp
e
antigen
like
other
seldom
produc
volunt
sera
taken
prior
infect
occasionmli
produc
convalesc
sera
taken
viru
infect
viru
antigen
seldom
produc
line
precipit
human
sera
even
convalesc
sera
vohmteer
develop
sever
cold
inocul
viru
reaction
observ
singl
line
detect
result
anim
antisera
lp
virus
homolog
antigen
amen
reliabl
interpret
profus
antitissu
line
appear
hand
hyperimmun
virusspecif
mous
ascit
produc
aib
serum
mhva
sera
sera
gave
clear
line
homolog
reaction
seen
fig
use
sera
crossreact
observ
neutral
complement
fixat
test
corrobor
interest
note
heterolog
line
produc
show
reaction
ident
homologantigen
relationship
n
g
coronavirus
human
coronavirus
neutral
antivir
antisera
greater
degre
complement
ad
system
contrast
neutral
avian
infecti
bronchiti
viru
complement
increas
neutral
index
sera
three
order
magnitud
berri
almeida
viru
also
neutral
antihost
cell
antisera
presenc
complement
unheat
guineapig
serum
produc
hole
viru
envelop
hole
also
produc
heterotyp
rabbit
homotyp
chicken
antisera
antihuman
antisera
produc
signific
neutral
either
lp
virus
complement
hole
produc
envelop
e
viru
homotyp
hcterotyp
human
antisera
almida
bradbva
unpublish
data
suggest
two
virus
differ
somewhat
assembl
infecti
bronchiti
viru
though
differ
detect
electronmicroscop
studi
worker
b
cker
et
al
could
due
amongst
thing
differ
surfac
structur
suscept
complement
enzym
complement
fixat
haemagglutinationinhibit
result
suggest
mhv
possess
sever
antigen
share
one
human
strain
work
show
lp
virus
close
relat
distinguish
serolog
crossreact
mhva
also
antisera
neutral
support
suggest
mcito
et
al
virus
form
one
uniform
group
serolog
group
heterogen
collect
serolog
distinct
character
crossreact
mhv
strain
use
human
sera
coronaviru
serolog
shown
limit
valu
differenti
infect
variou
human
coronavirus
heterolog
rise
found
sera
specif
antibodi
respons
probabl
occur
first
exposur
member
coronaviru
group
evid
respons
poor
may
boost
later
immunolog
stimul
two
anim
coronavirus
infecti
bronchiti
viru
seem
antigen
far
distant
human
coronavirus
mous
hepat
viru
mhva
fit
well
observ
htl
et
al
human
sera
contain
antibodi
mhv
may
rise
infect
miller
yat
detect
antibodi
human
sera
infecti
bronchiti
viru
except
person
contact
poultri
studi
antigen
structur
coronavirus
continu
antigen
respons
crossreact
may
isol
